Literature DB >> 319055

Induction of Escherichia coli and Vibrio cholerae enterotoxins by an inhibitor of protein synthesis.

M Levner, F P Wiener, B A Rubin.   

Abstract

Enterotoxigenic Escherichia coli or Vibrio cholerae 569B (Inaba) grown in the presence of the antibiotic lincomycin, an inhibitor of protein synthesis, produced elevated levels of heat-labile enterotoxin or choleragen, respectively, as assayed by both vascular permeability factor and capacity to elicit fluid accumulation in rabbit ileal loops. This induction of enterotoxin did not reflect either a coupling of lincomycin resistance with increased enterotoxigenicity or an effect of lincomycin on cellular release of enterotoxin, since spontaneously isolated lincomycin-resistant mutants of both E. coli and V. cholerae still required lincomycin for induction, and large increases in E. coli permeability factor activity were found intracellularly as well as extracellularly. After the period of exponential growth, E. coli became refractory to induction by lincomycin, although most of the induced enterotoxin activity appeared only after this period. No increase in copy number of the enterotoxin plasmid in E. coli 711 (P307) was found in induced cells by analysis of deoxyribonucleic acid reassociation kinetics. These and other data suggest that synthesis of enterotoxin, or at least its accumulation, is normally limited by cellular factors whose synthesis is preferentially inhibited by lincomycin. A possible connection between this phenomenon and lincomycin-associated diarrhea is considered.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319055      PMCID: PMC421338          DOI: 10.1128/iai.15.1.132-137.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Genetic and physical characteristics of an enterotoxin plasmid.

Authors:  D S Santos; S Palchaudhuri; W K Maas
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

2.  Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans.

Authors:  F J Skerman; S B Formal; S Falkow
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

3.  Repeated sequences in DNA. Hundreds of thousands of copies of DNA sequences have been incorporated into the genomes of higher organisms.

Authors:  R J Britten; D E Kohne
Journal:  Science       Date:  1968-08-09       Impact factor: 47.728

4.  Supercoiled circular DNA-protein complex in Escherichia coli: purification and induced conversion to an opern circular DNA form.

Authors:  D B Clewell; D R Helinski
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

5.  Partial denaturation of thymine- and 5-bromouracil-containing lambda DNA in alkali.

Authors:  R B Inman; M Schnös
Journal:  J Mol Biol       Date:  1970-04-14       Impact factor: 5.469

6.  Lincomycin, an inhibitor of aminoacyl sRNA binding to ribosomes.

Authors:  F N Chang; C J Sih; B Weisblum
Journal:  Proc Natl Acad Sci U S A       Date:  1966-02       Impact factor: 11.205

7.  The spectrum of colitis associated with lincomycin and clindamycin therapy.

Authors:  J L Le Frock; A S Klainer; S Chen; R B Gainer; M Omar; W Anderson
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

8.  Conjugal transfer of a chromosomal gene determining production of enterotoxin in vibrio cholerae.

Authors:  M L Vasil; R K Holmes; R A Finkelstein
Journal:  Science       Date:  1975-03-07       Impact factor: 47.728

9.  Production of vascular permeability factor by enterotoxigenic Escherichia coli isolated from man.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1973-11       Impact factor: 3.441

10.  Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli.

Authors:  D J Evans; D G Evans; S L Gorbach
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

View more
  34 in total

1.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  Purification of enterotoxins from Vibrio mimicus that appear to be identical to cholera toxin.

Authors:  W M Spira; P J Fedorka-Cray
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

3.  Lincomycin stimulates synthesis of TEM-2 beta-lactamase by Escherichia coli.

Authors:  A Okabe; O Matsushita; S Katayama; H Hayashi
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Lincomycin increases the half-life of beta-lactamase mRNA.

Authors:  O Matsushita; A Okabe; H Hayashi; Y Kanemasa
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

Review 5.  Pharmacokinetics of antibacterial agents in the CSF of children and adolescents.

Authors:  Amanda K Sullins; Susan M Abdel-Rahman
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

6.  Adaptation of the staphylococcal coagglutination technique for detection of heat-labile enterotoxin of Escherichia coli.

Authors:  B M Brill; B L Wasilauskas; S H Richardson
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

7.  The effect of adsorbant and anti-inflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli.

Authors:  C L Gyles; M Zigler
Journal:  Can J Comp Med       Date:  1978-07

8.  Assay method for Vibrio cholerae and Escherichia coli enterotoxins by automated counting of floating chinese hamster ovary cells in culture medium.

Authors:  R T Nozawa; T Yokota; S Kuwahara
Journal:  J Clin Microbiol       Date:  1978-05       Impact factor: 5.948

9.  Lincomycin increases synthetic rate and periplasmic pool size for cholera toxin.

Authors:  M H Levner; C Urbano; B A Rubin
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

10.  Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.

Authors:  W M Spira; P J Fedorka-Cray
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.